Perioperative considerations for patients with multiple myeloma
Abstract
Multiple myeloma is an incurable cancer characterised by clonal plasma-cell proliferation, arising predominantly in the bone marrow but producing widespread systemic complications. Additionally, this cancer usually presents in elderly patients who are often frail and suffering from multiple comorbidities. The global prevalence of multiple myeloma is steadily increasing, with therapeutic advances contributing to improved survival. There are several complications of multiple myeloma that the anaesthetist needs to be aware of arising from the disease itself, specific and supportive treatments adverse effects, as well as underlying patient complexities. The preoperative period demands a comprehensive, systematic assessment that identifies and optimises disease- and treatment-related complications, quantifies frailty, addresses anaemia through patient blood management principles, and stratifies thrombotic risk. Intraoperative management requires careful individualisation of anaesthetic technique in the absence of multiple myeloma-specific evidence-based guidelines, with particular vigilance directed at airway complexity, haemodynamic instability, heightened bleeding risk, and challenging pain management. Postoperative care must sustain these principles, with early attention to renal function, pain control, thromboprophylaxis, and the prompt recognition of the infectious complications to which this population is disproportionately vulnerable. Unfortunately, the literature on…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.